Last updated on April 2019

Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)


Brief description of study

To characterize dose response, and evaluate safety and efficacy of three different doses of EMA401 compared to placebo in patients with post-herpetic neuralgia (PHN)

Clinical Study Identifier: NCT03094195

Contact Investigators or Research Sites near you

Start Over

Novartis Investigative Site

Klagenfurt, Austria

Novartis Investigative Site

Vienna, Austria

Novartis Investigative Site

Odense C, Denmark

Novartis Investigative Site

Presov, Slovakia

Novartis Investigative Site

Darlington, United Kingdom

Novartis Investigative Site

Edinburgh, United Kingdom

Novartis Investigative Site

Liverpool, United Kingdom

Novartis Investigative Site

Erlangen, Germany

Novartis Investigative Site

Banska Bystrica, Slovakia

Novartis Investigative Site

Edegem, Belgium

Novartis Investigative Site

Lubbeek, Belgium

Novartis Investigative Site

Boulogne Billancourt, France

Novartis Investigative Site

Clermont-Ferrand, France

Novartis Investigative Site

Dresden, Germany

Novartis Investigative Site

Esztergom, Hungary

Novartis Investigative Site

Kecskemet, Hungary

Novartis Investigative Site

Szeged, Hungary

Novartis Investigative Site

Dubnica nad Vahom, Slovakia

Novartis Investigative Site

Ontario, ON Canada

Novartis Investigative Site

Levis, QC Canada

Novartis Investigative Site

Chocen, Czechia

Novartis Investigative Site

Berlin, Germany

Novartis Investigative Site

Wiesbaden, Germany

Novartis Investigative Site

Kistarcsa, Hungary

Novartis Investigative Site

Nishinomiya, Japan

Novartis Investigative Site

Yokohama-shi, Japan

Novartis Investigative Site

Yokohama, Japan

Novartis Investigative Site

Kawaguchi-city, Japan

Novartis Investigative Site

Shizuoka-shi, Japan

Novartis Investigative Site

Kasukabe-shi, Japan

Novartis Investigative Site

Olsztyn, Poland

Novartis Investigative Site

Almada, Portugal

Novartis Investigative Site

Leiria, Portugal

Novartis Investigative Site

Lisboa, Portugal

Novartis Investigative Site

Porto, Portugal

Novartis Investigative Site

Barcelona, Spain

Novartis Investigative Site

London, United Kingdom

Novartis Investigative Site

Praha 2, Czechia

Novartis Investigative Site

L Hospitalet De Llobregat, Spain

Novartis Investigative Site

Quebec, QC Canada

Novartis Investigative Site

Aveiro, Portugal

Novartis Investigative Site

Orange, Australia

Novartis Investigative Site

SAINT ETIENNE cedex 2, France

Novartis Investigative Site

Warszawa, Poland

Novartis Investigative Site

Valencia, Spain

Novartis Investigative Site

LILLE Cédex, France

Novartis Investigative Site

Leipzig, Germany

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.